These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9007409)

  • 21. [Mitochondrial encephalomyopathies starting in childhood and adolescence].
    Castro-Gago M; Novo-Rodríguez MI; Eirís-Puñal J
    Rev Neurol; 1998 Apr; 26 Suppl 1():S61-71. PubMed ID: 9810592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of deep intronic sequence exonization in a Japanese neonate with a mitochondrial trifunctional protein deficiency.
    Purevsuren J; Fukao T; Hasegawa Y; Fukuda S; Kobayashi H; Yamaguchi S
    Mol Genet Metab; 2008; 95(1-2):46-51. PubMed ID: 18693053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrauterine cardiomyopathy and cardiac mitochondrial proliferation in mitochondrial trifunctional protein (TFP) deficiency.
    Spiekerkoetter U; Mueller M; Cloppenburg E; Motz R; Mayatepek E; Bueltmann B; Korenke C
    Mol Genet Metab; 2008 Aug; 94(4):428-430. PubMed ID: 18485779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening.
    Spiekerkoetter U
    J Inherit Metab Dis; 2010 Oct; 33(5):527-32. PubMed ID: 20449660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disorders of fatty acid transport and mitochondrial oxidation: challenges and dilemmas of metabolic evaluation.
    Rinaldo P; Matern D
    Genet Med; 2000; 2(6):338-44. PubMed ID: 11339654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mitochondrial trifunctional protein].
    Uchiyama A; Yamaguchi S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():109-12. PubMed ID: 12013829
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial trifunctional protein deficiency in a lethal neonate.
    Yamazaki H; Torigoe K; Numata O; Haniu H; Uchiyama A; Ogawa Y; Kaneko U; Imamura M; Hasegawa S
    Pediatr Int; 2004 Apr; 46(2):178-80. PubMed ID: 15056246
    [No Abstract]   [Full Text] [Related]  

  • 29. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
    Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
    Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.
    Browning MF; Larson C; Strauss A; Marsden DL
    J Inherit Metab Dis; 2005; 28(4):545-50. PubMed ID: 15902557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein.
    Ojala T; Nupponen I; Saloranta C; Sarkola T; Sekar P; Breilin A; Tyni T
    Eur J Pediatr; 2015 Dec; 174(12):1689-92. PubMed ID: 26070998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of mitochondrial fatty acid oxidation defects.
    Duran M; Bruinvis L; Ketting D; Dorland L
    Padiatr Padol; 1993; 28(1):19-25. PubMed ID: 8446424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition and management of fatty acid oxidation defects: a series of 107 patients.
    Saudubray JM; Martin D; de Lonlay P; Touati G; Poggi-Travert F; Bonnet D; Jouvet P; Boutron M; Slama A; Vianey-Saban C; Bonnefont JP; Rabier D; Kamoun P; Brivet M
    J Inherit Metab Dis; 1999 Jun; 22(4):488-502. PubMed ID: 10407781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies.
    Fletcher AL; Pennesi ME; Harding CO; Weleber RG; Gillingham MB
    Mol Genet Metab; 2012 May; 106(1):18-24. PubMed ID: 22459206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement.
    den Boer ME; Dionisi-Vici C; Chakrapani A; van Thuijl AO; Wanders RJ; Wijburg FA
    J Pediatr; 2003 Jun; 142(6):684-9. PubMed ID: 12838198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.
    Wanders RJ; Ruiter JP; IJLst L; Waterham HR; Houten SM
    J Inherit Metab Dis; 2010 Oct; 33(5):479-94. PubMed ID: 20490924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physicians.
    Potter BK; Little J; Chakraborty P; Kronick JB; Evans J; Frei J; Sutherland SC; Wilson K; Wilson BJ
    J Inherit Metab Dis; 2012 Jan; 35(1):115-23. PubMed ID: 21630065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disorders of mitochondrial fatty acyl-CoA beta-oxidation.
    Wanders RJ; Vreken P; den Boer ME; Wijburg FA; van Gennip AH; IJlst L
    J Inherit Metab Dis; 1999 Jun; 22(4):442-87. PubMed ID: 10407780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.